3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Myeloid
1
Conditions
Melanoma
32
Neoplasms
14
Carcinoma, Non-Small-Cell Lung
10
Colorectal Neoplasms
8
Ovarian Neoplasms
7
Multiple Myeloma
6
Breast Neoplasms
6
Pancreatic Neoplasms
5
Neoplasm Metastasis
4
Hematologic Neoplasms
4
Solid Tumors
3
Neoplasms by Site
3
Lymphoma, Non-Hodgkin
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Gastrointestinal Neoplasms
3
Cholangiocarcinoma
3
Brain Neoplasms
3
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Thyroid Carcinoma, Anaplastic
2
Thyroid Cancer, Papillary
2
Solid Tumor
2
Skin Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Neoplasms by Histologic Type
2
Leukemia, Myelomonocytic, Chronic
2
Gallbladder Neoplasms
2
Fallopian Tube Neoplasms
2
Interventions
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Biopsy
2
ulixertinib
1
tipifarnib
1
tazemetostat
1
selpercatinib
1
pembrolizumab
1
palbociclib
1
olaparib
1
larotrectinib
1
ivosidenib
1
erdafitinib
1
ensartinib
1
cobimetinib
1
X-Rays
1
Vemurafenib
1
Radiation Dose Hypofractionation
1
Phantoms, Imaging
1
Nuclear Medicine Department, Hospital
1
Lenalidomide
1
LY3023414
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Histiocytic Sarcoma
×
cobimetinib
×
Clear all
NCT04079179
2025-09-18
NACHO-COBI
Baylor College of Medicine
Phase 2
Recruiting
90 enrolled